IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Athyrium Capital Management, LP

Q2 2023 Holdings

Filed 2023-08-14 | 7 holdings | $154.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biora Inc.Note 7.250% 12/074319FAB3$60.5M$103,500,00039.2%
Omeros CorpNOTE 5.250% 2/1682143AG7$52.8M$71,979,00034.2%
Omeros CorpNOTE 6.250%11/1682143AE2$11.0M$11,005,0007.2%
Paratek Pharmaceuticals Inc.NOTE 4.750% 5/0699374AB0$8.8M$9,000,0005.7%
RVL Pharmaceuticals PLCSHSG6S41R101$8.2M14,600,4445.3%
Biora Inc.COM74319F305$6.5M1,694,4814.2%
Puma Biotechnology Inc(PBYI)COM74587V107$6.3M1,792,1144.1%